Lisata Therapeutics President, COO Joshua Lehrer-Graiwer files initial beneficial ownership statement

• Lisata Therapeutics President and COO Joshua Lehrer-Graiwer filed a Form 3 reporting 21,548 shares held directly.
• Filing also lists 6,260 shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-037878), on September 28, 2026, and is solely responsible for the information contained therein.